Johnson & Johnson’s €4 Billion Registered Debt Offering
May 20, 2016
Cravath represented the underwriters, led by Bank of America Merrill Lynch, Deutsche Bank, Citigroup, Goldman, Sachs & Co. and J.P. Morgan Securities, in connection with the €4 billion registered debt offering of Johnson & Johnson, a company engaged in the manufacturing and sale of a broad range of products in the healthcare field. The notes were listed on the New York Stock Exchange. The transaction closed on May 20, 2016.
The Cravath team included partner Craig F. Arcella and associates Zara Bari and Alex L. Winkelman.
Related Practices & Industries
People
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
March 12, 2025
Johnson & Johnson’s $5 Billion Registered Notes Offering and Concurrent €4 Billion Notes Offering
Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.
